Moderna shares fell 5% today, ending the US session at $213.74, in a move that followed a week in which the stock was among the best performers in the S&P 500 healthcare sector.
Moderna (NASDAQ: MRNA) closed today at $213.74, down 5% on the session. No cause for the fall has been established.
Moderna’s daily close over the month to Monday, with today’s session marked.
An earlier big move
Moderna also moved by 5% or more on Tuesday last week, the 6th of October. The direction of that move has not been established.
Moderna’s daily changes over six months, with today’s move highlighted.
Recent company news
Moderna was added back to the Nasdaq-100 and said Juan Andres, a former manufacturing leader, would return as Chief Operating Officer to oversee scaling of its personalised cancer vaccine candidate, intismeran autogene, following positive Phase 3 melanoma results. The stock had been among the S&P 500 healthcare sector’s top gainers over the past week before today’s fall.
Sponsored content
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Moderna’s next results are due on the 5th of November.
The AskTraders Analyst Team features experts in technical and fundamental analysis, as well as traders specializing in stocks, forex, and cryptocurrency.
